L. Henderson, S. Canna, K. Friedman, M. Gorelik, S. Lapidus, H. Bassiri, E. Behrens, Anne Ferris, Kate F. Kernan, G. Schulert, P. Seo, M. Son, A. Tremoulet, R. Yeung, A. Mudano, Amy S Turner, D. Karp, J. Mehta
Arthritis & rheumatology, 2020
To provide guidance on the management of Multisystem Inflammatory Syndrome in Children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan dysfunction that manifests late in the course of severe acute respiratory syndrome coronavirus 2 (SARS–CoV‐2) infection. Recommendations are also provided for children with hyperinflammation during coronavirus disease 2019 (COVID‐19), the acute, infectious phase of SARS–CoV‐2 infection.
Cited by 50 publications.
Field of study: Medicine